Monica Forbes
Corporate Officer/Principal chez APOGEE THERAPEUTICS, INC.
Fortune : 33 626 $ au 31/05/2024
Postes actifs de Monica Forbes
Sociétés | Poste | Début | Fin |
---|---|---|---|
APOGEE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2023 | - |
Historique de carrière de Monica Forbes
Anciens postes connus de Monica Forbes
Sociétés | Poste | Début | Fin |
---|---|---|---|
CARISMA THERAPEUTICS, INC. | Directeur Financier/CFO | 01/08/2019 | 07/03/2023 |
Treasurer | - | 07/03/2023 | |
Nalpropion Pharmaceuticals, Inc.
Nalpropion Pharmaceuticals, Inc. Managed Health CareHealth Services Nalpropion Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the treatment of weight loss. Its products include CONTRAVE, analtrexone HCl & bupropion HCl extended release and Mysimba, a naltrexone HCl/ bupropion HCl prolonged release. The company is headquartered in Morristown, NJ. | Directeur Financier/CFO | 01/07/2018 | 01/04/2019 |
OREXIGEN THERAPEUTICS, INC. | Directeur Financier/CFO | 24/02/2018 | 27/07/2018 |
Corporate Officer/Principal | 01/10/2014 | 24/02/2018 |
Formation de Monica Forbes
San Diego State University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Opérationnelle
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
APOGEE THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Orexigen Therapeutics, Inc.
Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Nalpropion Pharmaceuticals, Inc.
Nalpropion Pharmaceuticals, Inc. Managed Health CareHealth Services Nalpropion Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the treatment of weight loss. Its products include CONTRAVE, analtrexone HCl & bupropion HCl extended release and Mysimba, a naltrexone HCl/ bupropion HCl prolonged release. The company is headquartered in Morristown, NJ. | Health Services |
- Bourse
- Insiders
- Monica Forbes
- Expérience